United States

Ceres Inc (CERE)

Track

Ticker: CERE
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Ambergate Trust Large shareholder
Transaction date
Purchase
Price
55.05
Quantity 19,929 +13.1%
Value US$1,359,648
Ambergate Trust Large shareholder
Transaction date
Purchase
Price
365.25
Quantity 4,859 -7.6%
Value US$3,641,903
Ambergate Trust Large shareholder
Transaction date
Purchase
Price
87.60
Quantity 53,868 +8.7%
Value US$1,409,534
Ambergate Trust Large shareholder
Transaction date
Purchase
Price
4.11
Quantity 266 +0.0%
Value US$1,093
Ambergate Trust Large shareholder
Transaction date
Purchase
Price
4.11
Quantity 300 +0.0%
Value US$1,233
Ambergate Trust Large shareholder
Transaction date
Purchase
Price
4.16
Quantity 27,200 +1.2%
Value US$113,089
Ambergate Trust Large shareholder
Transaction date
Purchase
Price
3.85
Quantity 24,544 +1.1%
Value US$94,494
Ambergate Trust Large shareholder
Transaction date
Purchase
Price
3.90
Quantity 73,546 +3.4%
Value US$286,756
Flavell Richard Bailey Chief Scientific Officer Executive Director
Transaction date
Planned sale
Price
8.67
Quantity 1,000 -0.9%
Value US$8,666
van Assche Wilfriede Margareta Maria SVP & Gen. Counsel & Secretary Officer
Transaction date
Planned sale
Price
8.81
Quantity 57 -0.4%
Value US$502
Flavell Richard Bailey Chief Scientific Officer Executive Director
Transaction date
Planned sale
Price
8.81
Quantity 267 -0.2%
Value US$2,351
van Assche Wilfriede Margareta Maria SVP & Gen. Counsel & Secretary Officer
Transaction date
Planned sale
Price
9.74
Quantity 350 -2.2%
Value US$3,410
Flavell Richard Bailey Chief Scientific Officer Executive Director
Transaction date
Planned sale
Price
9.74
Quantity 1,050 -0.9%
Value US$10,230
van Assche Wilfriede Margareta Maria SVP & Gen. Counsel & Secretary Officer
Transaction date
Planned sale
Price
9.17
Quantity 1,354 -7.5%
Value US$12,421
van Assche Wilfriede Margareta Maria SVP & Gen. Counsel & Secretary Officer
Transaction date
Planned sale
Price
8.70
Quantity 125 -0.7%
Value US$1,088
van Assche Wilfriede Margareta Maria SVP & Gen. Counsel & Secretary Officer
Transaction date
Planned sale
Price
7.20
Quantity 25 -0.1%
Value US$180
Flavell Richard Bailey Chief Scientific Officer Executive Director
Transaction date
Planned sale
Price
9.17
Quantity 4,061 -3.3%
Value US$37,253
Flavell Richard Bailey Chief Scientific Officer Executive Director
Transaction date
Planned sale
Price
8.70
Quantity 375 -0.3%
Value US$3,262
Flavell Richard Bailey Chief Scientific Officer Executive Director
Transaction date
Planned sale
Price
7.20
Quantity 75 -0.1%
Value US$540
van Assche Wilfriede Margareta Maria SVP & Gen. Counsel & Secretary Officer
Transaction date
Planned sale
Price
10.29
Quantity 90 -0.5%
Value US$926
Flavell Richard Bailey Chief Scientific Officer Executive Director
Transaction date
Planned sale
Price
10.29
Quantity 270 -0.2%
Value US$2,778
van Assche Wilfriede Margareta Maria SVP & Gen. Counsel & Secretary Officer
Transaction date
Planned sale
Price
10.02
Quantity 352 -1.8%
Value US$3,527
Flavell Richard Bailey Chief Scientific Officer Executive Director
Transaction date
Planned sale
Price
10.02
Quantity 1,058 -0.8%
Value US$10,602
Carlson Robert W Jr. See Remarks
Transaction date
Purchase
Price
9.95
Quantity 1,500 +18.8%
Value US$14,925
Carlson Robert W Jr. See Remarks
Transaction date
Purchase
Price
9.62
Quantity 3,000 +60.0%
Value US$28,860
van Assche Wilfriede Margareta Maria SVP & Gen. Counsel & Secretary Officer
Transaction date
Planned sale
Price
10.00
Quantity 50 -0.3%
Value US$500
Flavell Richard Bailey Chief Scientific Officer Executive Director
Transaction date
Planned sale
Price
10.00
Quantity 150 -0.1%
Value US$1,500
van Assche Wilfriede Margareta Maria SVP & Gen. Counsel & Secretary Officer
Transaction date
Planned sale
Price
10.79
Quantity 675 -3.3%
Value US$7,282
van Assche Wilfriede Margareta Maria SVP & Gen. Counsel & Secretary Officer
Transaction date
Planned sale
Price
10.00
Quantity 25 -0.1%
Value US$250
Flavell Richard Bailey Chief Scientific Officer Executive Director
Transaction date
Planned sale
Price
10.79
Quantity 2,025 -1.5%
Value US$21,846
Flavell Richard Bailey Chief Scientific Officer Executive Director
Transaction date
Planned sale
Price
10.00
Quantity 75 -0.1%
Value US$750
van Assche Wilfriede Margareta Maria SVP & Gen. Counsel & Secretary Officer
Transaction date
Planned sale
Price
10.95
Quantity 163 -0.8%
Value US$1,785
Flavell Richard Bailey Chief Scientific Officer Executive Director
Transaction date
Planned sale
Price
10.95
Quantity 486 -0.4%
Value US$5,323
Carlson Robert W Jr. See Remarks
Transaction date
Purchase
Price
10.12
Quantity 5,000 +inf%
Value US$50,600
Flavell Richard Bailey Chief Scientific Officer Executive Director
Transaction date
Planned sale
Price
10.20
Quantity 1,950 -1.5%
Value US$19,884
van Assche Wilfriede Margareta Maria SVP & Gen. Counsel & Secretary Officer
Transaction date
Planned sale
Price
10.20
Quantity 650 -3.0%
Value US$6,628
ARTAL LUXEMBOURG S A Large shareholder
Transaction date
Purchase
Price
13.00
Quantity 846,154 +26.4%
Value US$11,000,002
Ambergate Trust Large shareholder
Transaction date
Purchase
Price
13.00
Quantity 153,846 +7.7%
Value US$1,999,998
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2013-01-17 2013-01-16 B Purchase Ambergate Trust Large shareholder
19,929 +13.1%
55.05
US$1,359,648 		19,929 +13.1% 55.05 US$1,359,648
2013-01-16 2013-01-15 B Purchase Ambergate Trust Large shareholder
4,859 -7.6%
365.25
US$3,641,903 		4,859 -7.6% 365.25 US$3,641,903
2013-01-16 2013-01-14 B Purchase Ambergate Trust Large shareholder
53,868 +8.7%
87.60
US$1,409,534 		53,868 +8.7% 87.60 US$1,409,534
2013-01-09 2013-01-07 B Purchase Ambergate Trust Large shareholder
266 +0.0%
4.11
US$1,093 		266 +0.0% 4.11 US$1,093
2012-12-31 2012-12-28 B Purchase Ambergate Trust Large shareholder
300 +0.0%
4.11
US$1,233 		300 +0.0% 4.11 US$1,233
2012-12-31 2012-12-27 B Purchase Ambergate Trust Large shareholder
27,200 +1.2%
4.16
US$113,089 		27,200 +1.2% 4.16 US$113,089
2012-12-21 2012-12-20 B Purchase Ambergate Trust Large shareholder
24,544 +1.1%
3.85
US$94,494 		24,544 +1.1% 3.85 US$94,494
2012-12-21 2012-12-19 B Purchase Ambergate Trust Large shareholder
73,546 +3.4%
3.90
US$286,756 		73,546 +3.4% 3.90 US$286,756
2012-07-09 2012-07-09 PlS Planned sale Flavell Richard Bailey

Chief Scientific Officer

Executive Director
1,000 -0.9%
8.67
US$8,666 		1,000 -0.9% 8.67 US$8,666
2012-07-05 2012-07-05 PlS Planned sale van Assche Wilfriede Margareta Maria

SVP & Gen. Counsel & Secretary

Officer
57 -0.4%
8.81
US$502 		57 -0.4% 8.81 US$502
2012-07-05 2012-07-05 PlS Planned sale Flavell Richard Bailey

Chief Scientific Officer

Executive Director
267 -0.2%
8.81
US$2,351 		267 -0.2% 8.81 US$2,351
2012-06-27 2012-06-26 PlS Planned sale van Assche Wilfriede Margareta Maria

SVP & Gen. Counsel & Secretary

Officer
350 -2.2%
9.74
US$3,410 		350 -2.2% 9.74 US$3,410
2012-06-27 2012-06-26 PlS Planned sale Flavell Richard Bailey

Chief Scientific Officer

Executive Director
1,050 -0.9%
9.74
US$10,230 		1,050 -0.9% 9.74 US$10,230
2012-06-20 2012-06-19 PlS Planned sale van Assche Wilfriede Margareta Maria

SVP & Gen. Counsel & Secretary

Officer
1,354 -7.5%
9.17
US$12,421 		1,354 -7.5% 9.17 US$12,421
2012-06-20 2012-06-19 PlS Planned sale van Assche Wilfriede Margareta Maria

SVP & Gen. Counsel & Secretary

Officer
125 -0.7%
8.70
US$1,088 		125 -0.7% 8.70 US$1,088
2012-06-20 2012-06-19 PlS Planned sale van Assche Wilfriede Margareta Maria

SVP & Gen. Counsel & Secretary

Officer
25 -0.1%
7.20
US$180 		25 -0.1% 7.20 US$180
2012-06-20 2012-06-19 PlS Planned sale Flavell Richard Bailey

Chief Scientific Officer

Executive Director
4,061 -3.3%
9.17
US$37,253 		4,061 -3.3% 9.17 US$37,253
2012-06-20 2012-06-19 PlS Planned sale Flavell Richard Bailey

Chief Scientific Officer

Executive Director
375 -0.3%
8.70
US$3,262 		375 -0.3% 8.70 US$3,262
2012-06-20 2012-06-19 PlS Planned sale Flavell Richard Bailey

Chief Scientific Officer

Executive Director
75 -0.1%
7.20
US$540 		75 -0.1% 7.20 US$540
2012-06-08 2012-06-07 PlS Planned sale van Assche Wilfriede Margareta Maria

SVP & Gen. Counsel & Secretary

Officer
90 -0.5%
10.29
US$926 		90 -0.5% 10.29 US$926
2012-06-08 2012-06-07 PlS Planned sale Flavell Richard Bailey

Chief Scientific Officer

Executive Director
270 -0.2%
10.29
US$2,778 		270 -0.2% 10.29 US$2,778
2012-06-06 2012-06-05 PlS Planned sale van Assche Wilfriede Margareta Maria

SVP & Gen. Counsel & Secretary

Officer
352 -1.8%
10.02
US$3,527 		352 -1.8% 10.02 US$3,527
2012-06-06 2012-06-05 PlS Planned sale Flavell Richard Bailey

Chief Scientific Officer

Executive Director
1,058 -0.8%
10.02
US$10,602 		1,058 -0.8% 10.02 US$10,602
2012-07-11 2012-06-01 B Purchase Carlson Robert W Jr.

See Remarks
1,500 +18.8%
9.95
US$14,925 		1,500 +18.8% 9.95 US$14,925
2012-07-11 2012-05-31 B Purchase Carlson Robert W Jr.

See Remarks
3,000 +60.0%
9.62
US$28,860 		3,000 +60.0% 9.62 US$28,860
2012-06-01 2012-05-31 PlS Planned sale van Assche Wilfriede Margareta Maria

SVP & Gen. Counsel & Secretary

Officer
50 -0.3%
10.00
US$500 		50 -0.3% 10.00 US$500
2012-06-01 2012-05-31 PlS Planned sale Flavell Richard Bailey

Chief Scientific Officer

Executive Director
150 -0.1%
10.00
US$1,500 		150 -0.1% 10.00 US$1,500
2012-05-30 2012-05-29 PlS Planned sale van Assche Wilfriede Margareta Maria

SVP & Gen. Counsel & Secretary

Officer
675 -3.3%
10.79
US$7,282 		675 -3.3% 10.79 US$7,282
2012-05-30 2012-05-29 PlS Planned sale van Assche Wilfriede Margareta Maria

SVP & Gen. Counsel & Secretary

Officer
25 -0.1%
10.00
US$250 		25 -0.1% 10.00 US$250
2012-05-30 2012-05-29 PlS Planned sale Flavell Richard Bailey

Chief Scientific Officer

Executive Director
2,025 -1.5%
10.79
US$21,846 		2,025 -1.5% 10.79 US$21,846
2012-05-30 2012-05-29 PlS Planned sale Flavell Richard Bailey

Chief Scientific Officer

Executive Director
75 -0.1%
10.00
US$750 		75 -0.1% 10.00 US$750
2012-05-30 2012-05-25 PlS Planned sale van Assche Wilfriede Margareta Maria

SVP & Gen. Counsel & Secretary

Officer
163 -0.8%
10.95
US$1,785 		163 -0.8% 10.95 US$1,785
2012-05-30 2012-05-25 PlS Planned sale Flavell Richard Bailey

Chief Scientific Officer

Executive Director
486 -0.4%
10.95
US$5,323 		486 -0.4% 10.95 US$5,323
2012-07-11 2012-05-24 B Purchase Carlson Robert W Jr.

See Remarks
5,000 +inf%
10.12
US$50,600 		5,000 +inf% 10.12 US$50,600
2012-05-25 2012-05-24 PlS Planned sale Flavell Richard Bailey

Chief Scientific Officer

Executive Director
1,950 -1.5%
10.20
US$19,884 		1,950 -1.5% 10.20 US$19,884
2012-05-25 2012-05-24 PlS Planned sale van Assche Wilfriede Margareta Maria

SVP & Gen. Counsel & Secretary

Officer
650 -3.0%
10.20
US$6,628 		650 -3.0% 10.20 US$6,628
2012-02-28 2012-02-27 B Purchase ARTAL LUXEMBOURG S A Large shareholder
846,154 +26.4%
13.00
US$11,000,002 		846,154 +26.4% 13.00 US$11,000,002
2012-02-28 2012-02-27 B Purchase Ambergate Trust Large shareholder
153,846 +7.7%
13.00
US$1,999,998 		153,846 +7.7% 13.00 US$1,999,998
Explore more

More insider trading research around Ceres Inc

More insider trades in United States
Insider trading in North America